Protein C Deficiency

·MeSH: Protein C Deficiency

3 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
tak-662	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

Unknown(2)

Drug	Company
freeze-dried human protein c concentrate	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
freeze-dried human protein c concentrate	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)

BioSniper tracks 3 drugs in development for Protein C Deficiency across 2 companies.

There are 1 clinical trial targeting Protein C Deficiency tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.